Actinium Pharmaceuticals Inc (ATNM)
AMEX
The current ATNM market cap is 43.03M. The company's latest EPS is USD -1.5649 and P/E is -0.87.
Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 0 | 0 | 0 | 81k | 0 |
Operating Income | -11.58M | -15.64M | -14.35M | -10.34M | -9.6M |
Net Income | -11.04M | -15.18M | -13.28M | -9.32M | -8.67M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 0 | 0 | 1.14M | 1.03M | 81k |
Operating Income | -22.07M | -22.39M | -24.96M | -34.1M | -51.92M |
Net Income | -21.9M | -22.22M | -24.77M | -33.02M | -48.82M |
Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 102.03M | 99.05M | 88.94M | 81.45M | 88.35M |
Total Liabilities | 44.82M | 45.97M | 45.36M | 45.07M | 44.5M |
Total Equity | 57.21M | 53.08M | 43.58M | 36.38M | 43.86M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 11.67M | 66.4M | 80.39M | 114.19M | 81.45M |
Total Liabilities | 6.03M | 5.08M | 6.84M | 47.71M | 45.07M |
Total Equity | 5.64M | 61.32M | 73.55M | 66.48M | 36.38M |
Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -15.08M | -28.72M | -39.85M | -47.34M | -7.37M |
Investing | -76k | -123k | -153k | -153k | -11k |
Financing | 770k | 10.82M | 13.68M | 14.87M | 14.77M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -21.46M | -21.62M | -20.87M | 8.64M | -47.34M |
Investing | -64k | -253k | -133k | -366k | -153k |
Financing | 17.11M | 76.18M | 35.22M | 23.11M | 14.87M |
Market Cap | 43.03M |
Price to Earnings Ratio | -0.87 |
Price to Sales Ratio | 523.08 |
Price to Cash Ratio | 0.55 |
Price to Book Ratio | 1.17 |
Dividend Yield | - |
Shares Outstanding | 31.2M |
Average Volume (1 week) | 340.2k |
Average Volume (1 Month) | 302.45k |
52 Week Change | -73.16% |
52 Week High | 10.24 |
52 Week Low | 1.19 |
Spread (Intraday) | 0.01 (0.72%) |
Company Name | Actinium Pharmaceuticals Inc |
Address |
108 w. 13th street suite 100 wilmington, delaware 19801 |
Website | https://www.actiniumpharma.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.